Hemo Organic informs about quarterly statement of investor complaints

22 Jul 2017 Evaluate

Hemo Organic has submitted the Statement of Investor Complaints for the quarter June, 2017. The Company has not received any complaint during the quarter and there was no complaint outstanding for the resolution.

The above information is a part of company’s filings submitted to BSE.

Hemo Organic Share Price

14.92 -0.30 (-1.97%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×